Ubiquitination/ Proteasome


Once the substrate protein is labeled, proteasome will bind to a polyubiquitin chain, allowing the degradation of the labeled protein. The polyubiquitinated target protein is then recognized and degraded by the 26S proteasome. Deubiquitinating enzymes (DUBs) reverse the process of ubiquitination by removing ubiquitin from its substrate protein. Dysregulation of the ubiquitin-proteasome system has been linked to cancer, diabetes, cardiovascular and neurodegenerative diseases etc.
-
B5550 HBX 41108Summary: ubiquitin-specific protease (USP) 7 inhibitor -
A8693 C527Target: USP1/USF1 complexSummary: Inhibitor of USP1/USF1 complex -
A8716 LY3009120Target: RafSummary: pan-RAF and RAF dimer inhibitor -
A8715 SBI-02069652 CitationTarget: ULK1Summary: ULK1 inhibitor -
B5873 Spautin-11 CitationTarget: Deubiquitinating enzymes (DUBs)|AutophagySummary: Novel autophagy inhibitor -
B6026 VR23Target: ProteasomeSummary: proteasome inhibitor -
B6032 CB-508310 CitationTarget: p97Summary: p97 inhibitor -
A8172 Dihydroeponemycin1 CitationSummary: Proteasome inhibitor,antitumor reagent,eponemycin ddrivative -
B6107 ML241Summary: p97 ATPase inhibitor -
B6122 ML241 hydrochlorideSummary: p97 ATPase inhibitor

